Risk-factors for acquisition of extended-spectrum beta-lactamase- producing Escherichia coli among hospitalised patients
C. Pea, C. Gudiol, and F. Tubau Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients Clin Microbiol Infect 12 2006 279
A functional classification scheme for beta-lactamases and its correlation with molecular structure
K. Bush, G.A. Jacoby, and A.A. Medeiros A functional classification scheme for beta-lactamases and its correlation with molecular structure Antimicrob Agents Chemother 39 1995 1211
Characterization of extended-spectrum beta-lactamase (ESBL)-producing Kuwait and UK strains identified by the Vitek system, and subsequent comparison of the Vitek system with other commercial ESBL-testing systems using these strains
A.A. Dashti, P. West, and R. Paton Characterization of extended-spectrum beta-lactamase (ESBL)-producing Kuwait and UK strains identified by the Vitek system, and subsequent comparison of the Vitek system with other commercial ESBL-testing systems using these strains J Med Microbiol 55 2006 417
Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant
E.E. Prinarakis, V. Miriagou, and E. Tzelepi Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant Antimicrob Agents Chemother 41 1997 838
EUCAST Breakpoint tables for interpretation of MICs and zone diameters Version 1.3 http://www.eucast.org/clinical-breakpoints/ January 2011 Accessed March 18, 2011
Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals
J. Empel, A. Baraniak, and E. Literacka Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals Antimicrob Agents Chemother 52 2008 2449